# Single Versus Double Dose Intra-vaginal Prostaglandin E2 "Misoprostol" Prior Abdominal Myomectomy

> **NCT02154932** · PHASE4 · COMPLETED · sponsor: **Mansoura University** · enrollment: 69 (actual)

## Conditions studied

- Prostaglandin E2 "Misoprostol" Prior Abdominal Myomectomy

## Interventions

- **DRUG:** 2 doses 400 microgram misoprostol
- **DRUG:** single dose misoprostol

## Key facts

- **NCT ID:** NCT02154932
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2014-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02154932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02154932, "Single Versus Double Dose Intra-vaginal Prostaglandin E2 "Misoprostol" Prior Abdominal Myomectomy". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02154932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
